Nevro Corp (NVRO) - Product Pipeline Analysis, 2024 Update

Nevro Corp (Nevro) is a medical device company, which is engaged in developing novel products that advance the quality of life for people suffering from chronic pain in trunks and limbs. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacological neuromodulation platform for the treatment of chronic pain. The Nevro Senza SCS system is commercially available in Europe, the US, and Australia. The company offers products under Senza, Senza II, Senza Omnia and the Nevro logo brands. Nevro is developing HF10 therapy for treatment related to painful diabetic neuropathy and non-surgical refractory back pain. Nevro is headquartered in Redwood City, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Nevro Corp
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Nevro Corp Company Overview
Nevro Corp Company Snapshot
Nevro Corp Pipeline Products and Ongoing Clinical Trials Overview
Nevro Corp - Pipeline Analysis Overview
Business Description
Nevro Corp - Key Facts
Nevro Corp - Major Products and Services
Nevro Corp Pipeline Products by Development Stage
Nevro Corp Ongoing Clinical Trials by Trial Status
Nevro Corp Pipeline Products Overview
Senza HF10 Therapy System - Back Pain
Senza HF10 Therapy System - Back Pain Product Overview
Senza HF10 Therapy System - Chronic Abdominal Pain
Senza HF10 Therapy System - Chronic Abdominal Pain Product Overview
Senza HF10 Therapy System - Chronic Migraine
Senza HF10 Therapy System - Chronic Migraine Product Overview
Senza HF10 Therapy System - Chronic Neck Pain
Senza HF10 Therapy System - Chronic Neck Pain Product Overview
Senza HF10 Therapy System - CPSP
Senza HF10 Therapy System - CPSP Product Overview
Senza HF10 Therapy System - Leg Pain
Senza HF10 Therapy System - Leg Pain Product Overview
Senza HF10 Therapy System - Opioid Reduction
Senza HF10 Therapy System - Opioid Reduction Product Overview
Senza HF10 Therapy System - Painful Diabetic Neuropathy
Senza HF10 Therapy System - Painful Diabetic Neuropathy Product Overview
Senza HF10 Therapy System - Painful Diabetic Neuropathy Clinical Trial
Senza HF10 Therapy System - Pelvic Pain
Senza HF10 Therapy System - Pelvic Pain Product Overview
Senza HF10 Therapy System - Pelvic Pain Clinical Trial
Senza HF10 Therapy System - Peripheral Polyneuropathy
Senza HF10 Therapy System - Peripheral Polyneuropathy Product Overview
Senza HF10 Therapy System - Post-Surgical Pain
Senza HF10 Therapy System - Post-Surgical Pain Product Overview
Senza HF10 Therapy System - Rescue Therapy
Senza HF10 Therapy System - Rescue Therapy Product Overview
Senza HF10 Therapy System - Thoracic Pain
Senza HF10 Therapy System - Thoracic Pain Product Overview
Senza HF10 Therapy System - Upper Extremity Pain
Senza HF10 Therapy System - Upper Extremity Pain Product Overview
Senza HF10 Therapy System - Upper Limb Pain
Senza HF10 Therapy System - Upper Limb Pain Product Overview
Senza HFX iQ Spinal Cord Stimulation System
Senza HFX iQ Spinal Cord Stimulation System Product Overview
Nevro Corp - Key Competitors
Nevro Corp - Key Employees
Nevro Corp - Key Employee Biographies
Nevro Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Nevro Corp, Recent Developments
Feb 28, 2024: Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw
Feb 01, 2024: Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy
Jan 29, 2024: Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024
Jan 18, 2024: Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy
Jan 17, 2024: Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting
Jan 10, 2024: Nevro Laying Off 63 People To Strengthen Financial Position
Nov 20, 2023: Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain
Oct 04, 2023: Nevro to Report Third Quarter 2023 Financial Results
Sep 18, 2023: New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy
Aug 16, 2023: New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy
Appendix
Methodology
About the Analyst
Contact the Publisher
Disclaimer

List of Tables

Nevro Corp Pipeline Products and Ongoing Clinical Trials Overview
Nevro Corp Pipeline Products by Equipment Type
Nevro Corp Pipeline Products by Indication
Nevro Corp Ongoing Clinical Trials by Trial Status
Nevro Corp, Key Facts
Nevro Corp, Major Products and Services
Nevro Corp Number of Pipeline Products by Development Stage
Nevro Corp Pipeline Products Summary by Development Stage
Nevro Corp Ongoing Clinical Trials by Trial Status
Nevro Corp Ongoing Clinical Trials Summary
Senza HF10 Therapy System - Back Pain - Product Status
Senza HF10 Therapy System - Back Pain - Product Description
Senza HF10 Therapy System - Chronic Abdominal Pain - Product Status
Senza HF10 Therapy System - Chronic Abdominal Pain - Product Description
Senza HF10 Therapy System - Chronic Migraine - Product Status
Senza HF10 Therapy System - Chronic Migraine - Product Description
Senza HF10 Therapy System - Chronic Neck Pain - Product Status
Senza HF10 Therapy System - Chronic Neck Pain - Product Description
Senza HF10 Therapy System - CPSP - Product Status
Senza HF10 Therapy System - CPSP - Product Description
Senza HF10 Therapy System - Leg Pain - Product Status
Senza HF10 Therapy System - Leg Pain - Product Description
Senza HF10 Therapy System - Opioid Reduction - Product Status
Senza HF10 Therapy System - Opioid Reduction - Product Description
Senza HF10 Therapy System - Painful Diabetic Neuropathy - Product Status
Senza HF10 Therapy System - Painful Diabetic Neuropathy - Product Description
Senza HF10 Therapy System - Painful Diabetic Neuropathy - A Post-market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated with Diabetic Neuropathy
Senza HF10 Therapy System - Painful Diabetic Neuropathy - PDN-SENSORY: A Multi-Center Randomized Controlled Trial to Evaluate Pain and Neurological Function with 10 kHz SCS in Treatment of Painful Diabetic Neuropathy
Senza HF10 Therapy System - Pelvic Pain - Product Status
Senza HF10 Therapy System - Pelvic Pain - Product Description
Senza HF10 Therapy System - Pelvic Pain - A Prospective Clinical Study to Assess the Spinal Cord Stimulation System in the Treatment of Chronic Pelvic Pain
Senza HF10 Therapy System - Peripheral Polyneuropathy - Product Status
Senza HF10 Therapy System - Peripheral Polyneuropathy - Product Description
Senza HF10 Therapy System - Post-Surgical Pain - Product Status
Senza HF10 Therapy System - Post-Surgical Pain - Product Description
Senza HF10 Therapy System - Rescue Therapy - Product Status
Senza HF10 Therapy System - Rescue Therapy - Product Description
Senza HF10 Therapy System - Thoracic Pain - Product Status
Senza HF10 Therapy System - Thoracic Pain - Product Description
Senza HF10 Therapy System - Upper Extremity Pain - Product Status
Senza HF10 Therapy System - Upper Extremity Pain - Product Description
Senza HF10 Therapy System - Upper Limb Pain - Product Status
Senza HF10 Therapy System - Upper Limb Pain - Product Description
Senza HFX iQ Spinal Cord Stimulation System - Product Status
Senza HFX iQ Spinal Cord Stimulation System - Product Description
Nevro Corp, Key Employees
Nevro Corp, Key Employee Biographies
Nevro Corp, Subsidiaries
Glossary

List of Figures

Nevro Corp Pipeline Products by Equipment Type
Nevro Corp Pipeline Products by Development Stage
Nevro Corp Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

NeuSpera Medical Inc
Abbott Laboratories
Stimwave Technologies Inc
Saluda Medical Pty Ltd
Boston Scientific Corp
Medtronic Plc

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€735EUR$750USD£613GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€1471EUR$1,500USD£1,226GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€2206EUR$2,250USD£1,838GBP